Welcome
Support Centre
13 October 2008 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
UKCTG
mental health register
archived registers
all registers
tips on searching
 
Registration
submit trials
 
Information
about mRCT
mRCT FAQs
data items
memorandum
contributors

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
Ultra low dose anticoagulation in atrial fibrillation
Source of recordUK Clinical Trials Gateway
ISRCTNISRCTN17465143
Date ISRCTN assigned23/01/2004
Local reference number(s)MC7
Public titleUltra low dose anticoagulation in atrial fibrillation
Scientific title
AcronymN/A
Disease/condition/study domainCardiovascular diseases: Heart disease
Study hypothesisPrevious studies have demonstrated increased markers of thrombogenesis in patients with atrial fibrillation (AF), suggesting the presence of a hypercoaguable or prothromobotic state. The objective of this study was to determine the effects of introducing ultra-low-dose warfarin (1 mg), conventional warfarin, and aspirin (300 mg) therapy on thrombogenesis and platelet activation in AF.
Design/methodologyRandomised controlled trial
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteriaPatients with atrial fibrillation
Participants - exclusion criteriaNot provided at time of registration
Patient information material
Anticipated start date01/04/1994
Anticipated end date01/04/1996
Status of trialCompleted
Target number of participantsNot provided at time of registration
InterventionsNot provided at time of registration
Primary outcome measure(s)Platelet activation
Secondary outcome measure(s)Not provided at time of registration
Sources of fundingNHS Cardiovascular Disease and Stroke National Research and Development Programme
Sponsor nameRecord Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
Sponsor detailsThe Department of Health
Richmond House
79 Whitehall
London
United Kingdom
SW1A 2NL
Sponsor telephone+44 (0)20 7307 2622
Sponsor fax+44 (0)20 7307 2623
Sponsor emaildhmail@doh.gsi.org.uk
Sponsor websitehttp://www.doh.gov.uk
Contact nameProf Gareth Beevers
Contact detailsUniversity Department of Medicine
City Hospital
Dudley Rd
Birmingham
United Kingdom
B18 7QH
Contact telephone+44 (0)121 507 5080
Contact emailD.G.BEEVERS@bham.ac.uk
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN17465143
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol Top studies in medical research Submit to Trials journal
terms & conditions | privacy statement | © Current Controlled Trials Ltd


BioMed Central